1. Home
  2. GHG vs CABA Comparison

GHG vs CABA Comparison

Compare GHG & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

HOLD

Current Price

$1.74

Market Cap

205.1M

ML Signal

HOLD

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$2.43

Market Cap

200.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GHG
CABA
Founded
2004
2017
Country
China
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.1M
200.2M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
GHG
CABA
Price
$1.74
$2.43
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$13.50
AVG Volume (30 Days)
11.8K
2.6M
Earning Date
12-23-2025
11-10-2025
Dividend Yield
5.71%
N/A
EPS Growth
N/A
N/A
EPS
0.26
N/A
Revenue
$174,012,060.00
N/A
Revenue This Year
$19.02
N/A
Revenue Next Year
$8.26
N/A
P/E Ratio
$6.74
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.71
$0.99
52 Week High
$3.25
$3.67

Technical Indicators

Market Signals
Indicator
GHG
CABA
Relative Strength Index (RSI) 27.67 49.38
Support Level $1.66 $2.32
Resistance Level $1.89 $2.70
Average True Range (ATR) 0.08 0.18
MACD -0.01 0.01
Stochastic Oscillator 16.00 60.14

Price Performance

Historical Comparison
GHG
CABA

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: